GENOA VENTURES, LLC
GENOA VENTURES, LLC is a Seed and Series A fund in the US writing $500K–$5M checks into life-sciences, synthetic-biology, biotechnology, research-tools, diagnostics, agrifood, industrial-biology, animal-health and chemicals.
- Stages
- Seed, Series A
- Sectors
- life-sciences, synthetic-biology, biotechnology, research-tools, diagnostics, agrifood, industrial-biology, animal-health, chemicals
- Check size
- $500K–$5M
- Invests in
- US-wide
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2014
- Assets under management
- $150M+
Thesis
Genoa Ventures is a venture capital firm that invests in early-stage companies leveraging biology as a core technology, focusing on sectors such as life sciences, synthetic biology, biotechnology-enabled industries, research tools, diagnostics, AgriFood, industrial biology, animal health, and chemicals. The firm primarily invests in Seed and Series A rounds, with a preference for leading investment rounds, typically writing checks between $500,000 and $5 million. Their geographic scope is primarily North America, with a strong focus on the United States. Genoa Ventures manages over $150 million in assets, having closed Fund II at $84 million in August 2022. They aim to empower visionary entrepreneurs by providing not just capital but also strategic guidance and operational support to help companies scale effectively. The firm's team brings diverse experience in investing, operating, research, and scaling across biology and technology sectors.
Common questions
Does GENOA VENTURES, LLC invest at the Seed stage?
Yes. GENOA VENTURES, LLC lists Seed and Series A among the stages it invests in.
What check size does GENOA VENTURES, LLC write?
GENOA VENTURES, LLC writes $500K–$5M checks.
Where does GENOA VENTURES, LLC invest?
GENOA VENTURES, LLC invests in the US.